306 related articles for article (PubMed ID: 21303961)
1. Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
Desideri G; Panichi V; Paoletti S; Grassi D; Bigazzi R; Beati S; Bernabini G; Rosati A; Ferri C; Taddei S; Ghiadoni L;
Nephrol Dial Transplant; 2011 Sep; 26(9):2983-8. PubMed ID: 21303961
[TBL] [Abstract][Full Text] [Related]
2. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
[TBL] [Abstract][Full Text] [Related]
5. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
6. Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study.
Bellomo G; Lippi G; Saronio P; Reboldi G; Verdura C; Timio F; Timio M
J Nephrol; 2003; 16(2):245-51. PubMed ID: 12768072
[TBL] [Abstract][Full Text] [Related]
7. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study.
Panichi V; Rosati A; Bigazzi R; Paoletti S; Mantuano E; Beati S; Marchetti V; Bernabini G; Grazi G; Rizza GM; Migliori M; Giusti R; Lippi A; Casani A; Barsotti G; Tetta C;
Nephrol Dial Transplant; 2011 Aug; 26(8):2641-8. PubMed ID: 21325348
[TBL] [Abstract][Full Text] [Related]
8. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
9. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study.
Wu IW; Hsu KH; Hsu HJ; Lee CC; Sun CY; Tsai CJ; Wu MS
Nephrol Dial Transplant; 2012 Mar; 27(3):1169-75. PubMed ID: 21891772
[TBL] [Abstract][Full Text] [Related]
10. Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up.
Lenart-Lipińska M; Matyjaszek-Matuszek B; Gernand W; Nowakowski A; Solski J
Diabetes Res Clin Pract; 2013 Aug; 101(2):194-200. PubMed ID: 23768789
[TBL] [Abstract][Full Text] [Related]
11. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
[TBL] [Abstract][Full Text] [Related]
12. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
13. Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.
Koch M; Kohnle M; Trapp R; Haastert B; Rump LC; Aker S
Nephrol Dial Transplant; 2012 Jan; 27(1):375-80. PubMed ID: 21622993
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD40L: risk prediction after acute coronary syndromes.
Varo N; de Lemos JA; Libby P; Morrow DA; Murphy SA; Nuzzo R; Gibson CM; Cannon CP; Braunwald E; Schönbeck U
Circulation; 2003 Sep; 108(9):1049-52. PubMed ID: 12912804
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
16. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.
Kyriazis J; Tzanakis I; Stylianou K; Katsipi I; Moisiadis D; Papadaki A; Mavroeidi V; Kagia S; Karkavitsas N; Daphnis E
Nephrol Dial Transplant; 2011 Sep; 26(9):2971-7. PubMed ID: 21427069
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.
Amabile N; Guérin AP; Tedgui A; Boulanger CM; London GM
Nephrol Dial Transplant; 2012 May; 27(5):1873-80. PubMed ID: 22036944
[TBL] [Abstract][Full Text] [Related]
18. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
Okuno S; Ishimura E; Kohno K; Fujino-Katoh Y; Maeno Y; Yamakawa T; Inaba M; Nishizawa Y
Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD40 ligand in haemodialysis patients: survival impact and cardiovascular prognostic role.
Rusu C; Racasan S; Moldovan D; Kacso IM; Potra A; Bondor CI; Patiu IM; Vladutiu D; Caprioara MG
Biomarkers; 2017; 22(3-4):232-238. PubMed ID: 27295448
[TBL] [Abstract][Full Text] [Related]
20. Predictive role of BNP and NT-proBNP in hemodialysis patients.
Sun L; Sun Y; Zhao X; Xu C; Chen D; Li L; Ma Y; Rong S; Mei C
Nephron Clin Pract; 2008; 110(3):c178-84. PubMed ID: 18957868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
